- Home
- PHVS vs KMT Comparison
PHVS vs KMT Comparison
Compare PHVS & KMT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- PHVS
- KMT
- Stock Information
- Founded
- PHVS 2015
- KMT 1938
- Country
- PHVS Switzerland
- KMT United States
- Employees
- PHVS N/A
- KMT N/A
- Industry
- PHVS Biotechnology: Pharmaceutical Preparations
- KMT Industrial Machinery/Components
- Sector
- PHVS Health Care
- KMT Industrials
- Exchange
- PHVS Nasdaq
- KMT Nasdaq
- Market Cap
- PHVS 1.6B
- KMT 1.6B
- IPO Year
- PHVS 2021
- KMT N/A
- Fundamental
- Price
- PHVS $22.46
- KMT $22.16
- Analyst Decision
- PHVS Buy
- KMT Hold
- Analyst Count
- PHVS 6
- KMT 6
- Target Price
- PHVS $36.50
- KMT $24.00
- AVG Volume (30 Days)
- PHVS 217.3K
- KMT 711.3K
- Earning Date
- PHVS 11-12-2025
- KMT 11-05-2025
- Dividend Yield
- PHVS N/A
- KMT 3.61%
- EPS Growth
- PHVS N/A
- KMT N/A
- EPS
- PHVS N/A
- KMT 1.20
- Revenue
- PHVS N/A
- KMT $1,966,845,000.00
- Revenue This Year
- PHVS N/A
- KMT $2.40
- Revenue Next Year
- PHVS N/A
- KMT $3.62
- P/E Ratio
- PHVS N/A
- KMT $18.48
- Revenue Growth
- PHVS N/A
- KMT N/A
- 52 Week Low
- PHVS $11.51
- KMT $17.30
- 52 Week High
- PHVS $26.33
- KMT $32.18
- Technical
- Relative Strength Index (RSI)
- PHVS 47.79
- KMT 51.19
- Support Level
- PHVS $21.99
- KMT $22.50
- Resistance Level
- PHVS $23.64
- KMT $23.22
- Average True Range (ATR)
- PHVS 1.28
- KMT 0.50
- MACD
- PHVS -0.01
- KMT -0.05
- Stochastic Oscillator
- PHVS 52.17
- KMT 30.36
About PHVS Pharvaris N.V.
Pharvaris NV is a late-stage biopharmaceutical company which is engaged in developing novel, oral bradykinin B2 receptor antagonists to prevent and treat HAE attacks. By directly pursuing this clinically therapeutic target with novel small molecules, With positive data in both Phase 2 prophylaxis and studies in HAE, Pharvaris is developing deucrictibant. Pharvaris is currently enrolling a pivotal Phase 3 study for the treatment of HAE attacks and plans to initiate a pivotal Phase 3 study of deucrictibant for the prevention of HAE attacks.
About KMT Kennametal Inc.
Kennametal Inc is a manufacturer of metalworking tools and wear-resistant engineered components and coatings. The company operates in two business segments; Metal Cutting and Infrastructure. It generates maximum revenue from the Metal Cutting segment. The Metal Cutting segment develops and manufactures high-performance tooling and metal cutting products and services and offers an assortment of standard and custom metal cutting solutions to diverse end markets, including aerospace, general engineering, energy, and transportation. Geographically, it derives maximum revenue from the United States and the rest from Germany, China, Canada, India, Italy, and other countries.